<乌鸦传媒>Nuanced View of Oral Sex, HPV+ Oropharyngeal Cancer Age at first oral sex, 'intensity,' number of partners all influence risk Jan 13, 2021
<乌鸦传媒>Is This Really Cancer? Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<乌鸦传媒>Most Women Satisfied With 'Going Flat' After Mastectomy Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<乌鸦传媒>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<乌鸦传媒>Targeted Combo Fails in EGFR-Mutant NSCLC Osimertinib-bevacizumab no better than osimertinib alone Jan 07, 2021
<乌鸦传媒>Baby Boys Get Cancer From Mom During Birth Report highlights potential fetal implications of undiagnosed maternal cervical cancer Jan 06, 2021
<乌鸦传媒>PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<乌鸦传媒>Young-Onset Esophageal Cancer Rapidly Increasing Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
<乌鸦传媒>Add-On HDAC Inhibitor No Help in Breast Cancer PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<乌鸦传媒>Broader Role for PARP Inhibitors in Breast Cancer? Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<乌鸦传媒>Online Tool Refines Individual Risks in Breast Cancer RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
<乌鸦传媒>Doctor-Patient Discord in Reporting Radiation Toxicity Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
<乌鸦传媒>Non-Hodgkin Lymphoma: Bispecific Antibodies Impress in Refractory Disease Odronextamab, epcoritamab surpass 90% response threshold in early trials Dec 11, 2020
<乌鸦传媒>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancer No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<乌鸦传媒>Chemo-Free Combo Boosts PFS in First-Line CLL PI3K-delta-based regimen also topped chemoimmunotherapy in relapsed setting Dec 08, 2020
<乌鸦传媒>Novel Agent Active in Refractory CML Asciminib doubles molecular response versus bosutinib after two or more prior lines of therapy Dec 08, 2020
<乌鸦传媒>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Study Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<乌鸦传媒>Gene Therapy Stops Bleeding in Hemophilia Single injection had durable effectiveness, study showed Dec 08, 2020
<乌鸦传媒>Chemotherapy Improved TNBC Survival in Older Women Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<乌鸦传媒>Tranexamic Acid May Hurt Head Trauma Survival for One Key Group Cheap antifibrinolytic given en route to hospital safe overall in registry Dec 07, 2020
<乌鸦传媒>Fixed-Duration Ibrutinib-Venetoclax Promising in First-Line CLL DFS at 1 year reaches 95% in patients with undetectable MRD Dec 06, 2020
<乌鸦传媒>CRISPR-Based Tx Offers Hope in Tough-to-Treat Blood Disorders Success with investigational use of gene editing in sickle cell disease, beta-thalassemia Dec 06, 2020
<乌鸦传媒>Blood Cancers and COVID-19: 'A Medically Vulnerable' Group Patients with hematologic malignancies and SARS-CoV-2 face higher risks for infection, death Dec 06, 2020
<乌鸦传媒>JAK Inhibitor Wins in Second-Line Chronic GVHD Twice as many patients achieved a response at week 24 Dec 05, 2020
<乌鸦传媒>Sickle Cell Disease Tied to Worse COVID-19 Outcomes Black patients seem to be at higher risk for certain COVID-19 complications, death Dec 05, 2020
<乌鸦传媒>Three-Drug Regimen Reduces Myeloma Treatment Burden Efficacy maintained with addition of SQ daratumumab to pomalidomide, dexamethasone Dec 04, 2020
<乌鸦传媒>Bone Marrow Improves Healing With ACL Grafts MRI confirms better outcomes than with allograft alone in randomized study Dec 04, 2020
<乌鸦传媒>FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<乌鸦传媒>Study Reassures on MS Patients' Breast, Colorectal Cancer Risk But higher incidence of other cancers in Canadian data Nov 25, 2020
<乌鸦传媒>Potential New Option in Aggressive, Ultra Rare Sarcoma Highly durable responses with nab-sirolimus in malignant PEComa Nov 21, 2020
<乌鸦传媒>Cellular Therapies Promising in Advanced Synovial Sarcoma Two different strategies yield impressive results in patients with recurrent or metastatic disease Nov 20, 2020
<乌鸦传媒>Tiny Lung Micronodules in Bone Sarcoma Not Even a Tiny Problem? Five-year survival no worse in patients with micronodules under 5 mm Nov 20, 2020
<乌鸦传媒>Lorlatinib Shows 'Striking' CNS Activity in ALK Lung Cancer But unusual adverse events may hold therapy back Nov 18, 2020
<乌鸦传媒>New Clinical Strategy for HR-Positive Breast Cancer? Ki67 values before, after preop endocrine therapy associated with recurrence risk Nov 17, 2020
<乌鸦传媒>IL-8 Antibody Active in Tumors After PD-1/L1 Blockade Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<乌鸦传媒>PD-1 Inhibitor Active in Progressive Basal Cell Cancer Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<乌鸦传媒>Al Roker's Prostate Cancer Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
<乌鸦传媒>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
<乌鸦传媒>IVF Babies With Birth Defects Also Show Increased Cancer Risk Absolute risk is small, but findings should prompt further research Oct 29, 2020
